Analysis of the androgen receptor in isolated testicular cell types with a microassay that uses an affinity ligand

Catherine Tananis Anthony, William J. Kovacs, Michael K. Skinner

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

A microassay for the androgen receptor was developed to investigate the cellular distribution of receptor in freshly isolated testicular cell types. The microassay uses an androgen affinity ligand, 17β-dihydrotestosterone bromoacetate. Binding of this ligand by the androgen receptor is rapid and irreversible, which permits the development of a highly sensitive assay. The androgen receptor microassay is completed within 4 h and detects receptor in as little as 0.5 μg cellular protein. There was no detectable binding of the affinity label by albumin or Sertoli cell-secreted proteins, including androgen-binding protein. Androgen receptor was found in cellular sonicates of human foreskin fibroblast, rat ventral prostate, rat kidney, and rat liver. Although the relative distribution of receptor was similar to that obtained using a traditional equilibrium binding assay, the levels of receptor were significantly higher using the microassay. The androgen receptor microassay was subsequently used to investigate the receptor in isolated testicular cell types. Androgen receptor was detected in freshly isolated peritubular myoid cells (80 fmol/μg DNA), Sertoli cells (88 fmol/μg DNA), and Leydig cells (35 fmol/μg DNA). No androgen receptor was detected in a mixed population of germ cells. Hormones were not found to influence androgen receptor levels in cultured peritubular cells or Sertoli cells. Electrophoretic analysis of androgen receptor radiolabeled with the affinity ligand demonstrates a single 52-kDa form of the receptor in peritubular cells, Sertoli cells, and Leydig cells. The size of the androgen receptor species detected in the rat testicular cell types was slightly smaller than the 56- kDa protein detected in a human fibroblast cell line. The current study demonstrates the utility of the microassay and affinity ligand to investigate androgen receptor biology. Data indicate that androgen receptors are present in several testicular cell types and suggest that the control of testicular function by androgens probably involves actions on multiple cell types.

Original languageEnglish (US)
Pages (from-to)2628-2635
Number of pages8
JournalEndocrinology
Volume125
Issue number5
DOIs
StatePublished - Nov 1989

Fingerprint

Androgen Receptors
Ligands
Sertoli Cells
Leydig Cells
Androgens
DNA
Fibroblasts
Androgen-Binding Protein
Affinity Labels
Foreskin
Proteins
Germ Cells
Prostate
Albumins
Cultured Cells
Hormones
Kidney

All Science Journal Classification (ASJC) codes

  • Endocrinology

Cite this

@article{00e4fb8e432f405b8d7a8a265b846619,
title = "Analysis of the androgen receptor in isolated testicular cell types with a microassay that uses an affinity ligand",
abstract = "A microassay for the androgen receptor was developed to investigate the cellular distribution of receptor in freshly isolated testicular cell types. The microassay uses an androgen affinity ligand, 17β-dihydrotestosterone bromoacetate. Binding of this ligand by the androgen receptor is rapid and irreversible, which permits the development of a highly sensitive assay. The androgen receptor microassay is completed within 4 h and detects receptor in as little as 0.5 μg cellular protein. There was no detectable binding of the affinity label by albumin or Sertoli cell-secreted proteins, including androgen-binding protein. Androgen receptor was found in cellular sonicates of human foreskin fibroblast, rat ventral prostate, rat kidney, and rat liver. Although the relative distribution of receptor was similar to that obtained using a traditional equilibrium binding assay, the levels of receptor were significantly higher using the microassay. The androgen receptor microassay was subsequently used to investigate the receptor in isolated testicular cell types. Androgen receptor was detected in freshly isolated peritubular myoid cells (80 fmol/μg DNA), Sertoli cells (88 fmol/μg DNA), and Leydig cells (35 fmol/μg DNA). No androgen receptor was detected in a mixed population of germ cells. Hormones were not found to influence androgen receptor levels in cultured peritubular cells or Sertoli cells. Electrophoretic analysis of androgen receptor radiolabeled with the affinity ligand demonstrates a single 52-kDa form of the receptor in peritubular cells, Sertoli cells, and Leydig cells. The size of the androgen receptor species detected in the rat testicular cell types was slightly smaller than the 56- kDa protein detected in a human fibroblast cell line. The current study demonstrates the utility of the microassay and affinity ligand to investigate androgen receptor biology. Data indicate that androgen receptors are present in several testicular cell types and suggest that the control of testicular function by androgens probably involves actions on multiple cell types.",
author = "Anthony, {Catherine Tananis} and Kovacs, {William J.} and Skinner, {Michael K.}",
year = "1989",
month = "11",
doi = "10.1210/endo-125-5-2628",
language = "English (US)",
volume = "125",
pages = "2628--2635",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "5",

}

Analysis of the androgen receptor in isolated testicular cell types with a microassay that uses an affinity ligand. / Anthony, Catherine Tananis; Kovacs, William J.; Skinner, Michael K.

In: Endocrinology, Vol. 125, No. 5, 11.1989, p. 2628-2635.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Analysis of the androgen receptor in isolated testicular cell types with a microassay that uses an affinity ligand

AU - Anthony, Catherine Tananis

AU - Kovacs, William J.

AU - Skinner, Michael K.

PY - 1989/11

Y1 - 1989/11

N2 - A microassay for the androgen receptor was developed to investigate the cellular distribution of receptor in freshly isolated testicular cell types. The microassay uses an androgen affinity ligand, 17β-dihydrotestosterone bromoacetate. Binding of this ligand by the androgen receptor is rapid and irreversible, which permits the development of a highly sensitive assay. The androgen receptor microassay is completed within 4 h and detects receptor in as little as 0.5 μg cellular protein. There was no detectable binding of the affinity label by albumin or Sertoli cell-secreted proteins, including androgen-binding protein. Androgen receptor was found in cellular sonicates of human foreskin fibroblast, rat ventral prostate, rat kidney, and rat liver. Although the relative distribution of receptor was similar to that obtained using a traditional equilibrium binding assay, the levels of receptor were significantly higher using the microassay. The androgen receptor microassay was subsequently used to investigate the receptor in isolated testicular cell types. Androgen receptor was detected in freshly isolated peritubular myoid cells (80 fmol/μg DNA), Sertoli cells (88 fmol/μg DNA), and Leydig cells (35 fmol/μg DNA). No androgen receptor was detected in a mixed population of germ cells. Hormones were not found to influence androgen receptor levels in cultured peritubular cells or Sertoli cells. Electrophoretic analysis of androgen receptor radiolabeled with the affinity ligand demonstrates a single 52-kDa form of the receptor in peritubular cells, Sertoli cells, and Leydig cells. The size of the androgen receptor species detected in the rat testicular cell types was slightly smaller than the 56- kDa protein detected in a human fibroblast cell line. The current study demonstrates the utility of the microassay and affinity ligand to investigate androgen receptor biology. Data indicate that androgen receptors are present in several testicular cell types and suggest that the control of testicular function by androgens probably involves actions on multiple cell types.

AB - A microassay for the androgen receptor was developed to investigate the cellular distribution of receptor in freshly isolated testicular cell types. The microassay uses an androgen affinity ligand, 17β-dihydrotestosterone bromoacetate. Binding of this ligand by the androgen receptor is rapid and irreversible, which permits the development of a highly sensitive assay. The androgen receptor microassay is completed within 4 h and detects receptor in as little as 0.5 μg cellular protein. There was no detectable binding of the affinity label by albumin or Sertoli cell-secreted proteins, including androgen-binding protein. Androgen receptor was found in cellular sonicates of human foreskin fibroblast, rat ventral prostate, rat kidney, and rat liver. Although the relative distribution of receptor was similar to that obtained using a traditional equilibrium binding assay, the levels of receptor were significantly higher using the microassay. The androgen receptor microassay was subsequently used to investigate the receptor in isolated testicular cell types. Androgen receptor was detected in freshly isolated peritubular myoid cells (80 fmol/μg DNA), Sertoli cells (88 fmol/μg DNA), and Leydig cells (35 fmol/μg DNA). No androgen receptor was detected in a mixed population of germ cells. Hormones were not found to influence androgen receptor levels in cultured peritubular cells or Sertoli cells. Electrophoretic analysis of androgen receptor radiolabeled with the affinity ligand demonstrates a single 52-kDa form of the receptor in peritubular cells, Sertoli cells, and Leydig cells. The size of the androgen receptor species detected in the rat testicular cell types was slightly smaller than the 56- kDa protein detected in a human fibroblast cell line. The current study demonstrates the utility of the microassay and affinity ligand to investigate androgen receptor biology. Data indicate that androgen receptors are present in several testicular cell types and suggest that the control of testicular function by androgens probably involves actions on multiple cell types.

UR - http://www.scopus.com/inward/record.url?scp=0024427527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024427527&partnerID=8YFLogxK

U2 - 10.1210/endo-125-5-2628

DO - 10.1210/endo-125-5-2628

M3 - Article

C2 - 2792002

AN - SCOPUS:0024427527

VL - 125

SP - 2628

EP - 2635

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 5

ER -